Palliative Care Flashcards
1. A patient is taking 2 oxycodone/acetaminophen tablets (5 mg/325 mg), 6 times a day. What is the equivalent dose of a long-acting morphine preparation? A. 15 mg q12 B. 15 mg q8h C. 30 mg q12 D. 30 mg q8h E. 45 mg q12
C
2.
Mrs. Jensen is a 72 year/old woman with multiple sclerosis. She is dying, is at home, and has severe
pain, currently receiving MS Contin 60 mg q12h and prn oral hydromorphone. The home hospice nurse
feels she needs parenteral opioids. She is unable to swallow medication and has no intravenous access.
Which of the following is the most appropriate route to recommend for opioid analgesic administration?
A. Intramuscular
B. Intravenous via Hickman catheter or Mediport
C. Intravenous via PICC line catheter
D. Intravenous via peripheral IV catheter
E. Subcutaneous
E
3.
A 67 y/o man with prostate cancer has increasingly severe pain over the Left hip. Over the past two
weeks the pain has worsened requiring increasing doses of opioid analgesics. The pain is constant,
aching and well localized; there is no referred pain. Increasing pain in this patient most likely represents:
A. Drug seeking behavior
B. New onset depression
C. Opioid addiction
D. Opioid tolerance
E. Worsening metastatic cancer
E
4. Pain that is described as “dull, achy” and is well localized, is best described as: A. Autonomic pain B. Neuropathic pain C. Somatic pain D. Vascular pain E. Visceral pain
C
5. After ingesting a dose of acetaminophen/oxycodone (Percocet), when would you expect a patient to report the maximal analgesic effect; in: A. 10--15 minutes B. 30--45 minutes C. 60--90 minutes D. 120-150 minutes E. 180-210 minutes
C
6.
A patient is taking 12 oxycodone/acetaminophen tablets (5/325) per day with only partial relief. The most
appropriate next step in drug therapy for this patient would be to discontinue Percocet, and start:
A. oral hydrocodone (e.g. Vicodin, Lortab)
B. oral hydromorphone (Dilaudid)
C. oral long-acting morphine (e.g. MS Contin, Oramorph SR)
D. oral meperidine (Demerol)
E. oral tramadol (Ultram)
C
7. The most appropriate adjuvant analgesic for use when treating somatic pain is: A. amitriptyline (Elavil) B. clonidine (Catapres) C. ibuprofen (Motrin) D. lorazepam (Ativan) E. neurontin (Gabapentin)
C
8. The most appropriate adjuvant analgesic for use when treating neuropathic pain is: A. clonidine (Catapres) B. dexamethasone (Decadron) C. ibuprofen (e.g. Motrin) D. lorazepam (Ativan) E. nortriptyline (Pamelor)
E
9. The most appropriate first drug to prescribe to prevent opioid constipation is: A. docusate (Colace) B. bisacodyl (Dulcolax) C. lactulose (Chronulac) D. metoclopramide (Reglan) E. senna concentrate (Senokot)
E
10.
A 27 y/o woman with AIDS notes burning pain along the bottom of both feet. There is often a numbing
sensation; the pain limits her ability to walk. She recently began taking acetaminophen with codeine, 2
tabs q4H. She says the medicine provides no relief and it makes her feel sleepy. This woman’s pain is
best described as:
A. Autonomic pain
B. Neuropathic pain
C. Somatic pain
D. Vascular pain
E. Visceral pain
B
11. Oral hydromorphone (Dilaudid) can be safely administered for pain as often as every: A. 2 hours B. 3 hours C. 4 hours D. 5 hours E. 6 hours
A
12.
Which one of the following statements concerning nausea while taking opioids is true:
A. Nausea to opioids is due to bowel distention and stimulation of the vagus nerve
B. Nausea to opioids is due to decreased bowel motility
C. Nausea to opioids is usually accompanied with itching
D. Nausea to opioids represents a drug allergy
E. Nausea to opioids resolves in most patients within 7 days
E
13. Because of delayed onset of activity after the first application of a Duragesic Patch (transdermal fentanyl), it is especially important to have breakthrough pain medicine available for the first: A. 2-6 hours B. 7-12 hours C. 13-24 hours D. 24-36 hours E. 48-72 hours
C
14. Compared to morphine, which one of the following opioids is more likely to result in respiratory depression during dose escalation: A. hydrocodone (e.g. Vicodin or Lortab) B. hydromorphone (Dilaudid) C. meperidine (Demerol) D. methadone (Dolophine) E. oxycodone (e.g. Percocet)
D
15. For patients on chronic opioids, the most appropriate equianalgesic conversion ratio between oral and intravenous morphine is: A. 3 mg oral = 18 mg intravenous B. 3 mg oral = 9 mg intravenous C. 3 mg oral = 3 mg intravenous D. 3 mg oral = 1 mg intravenous E. 3 mg oral = 0.3 mg intravenous
D
16. The most appropriate equianalgesic conversion ratio between IV morphine and IV hydromorphone (Dilaudid) is: A. 1 mg morphine = 8 mg hydromorphone B. 1 mg morphine = 4 mg hydromorphone C. 1 mg morphine = 1 mg hydromorphone D. 1 mg morphine = 0.50 mg hydromorphone E. 1 mg morphine = 0.20 mg hydromorphone
E
17. The most appropriate equianalgesic conversion ration between IV morphine and Subcutaneous morphine is: A. 1.0 mg IV = 0.25 mg SQ B. 1.0 mg IV = 0.5 mg SQ C. 1.0 mg IV = 1.0 mg SQ D. 1.0 mg IV = 2.0 mg SQ E. 1.0 mg IV = 4.0 mg SQ
C
18.
The single best indicator of opioid drug addiction (psychological dependence) is:
A. An increasing need for the drug over time
B. Complaint of pain exceeding that expected for a given medical problem
C. Development of a withdrawal syndrome when the drug is stopped
D. Evidence of adverse life consequences from drug use
E. Requesting a specific opioid by name
D
19. Which of the following drugs has been shown to improve appetite in advanced cancer patients: A. conjugated estrogen (e.g. Premarin) B. haloperidol (Haldol) C. lorazepam (Ativan) D. megesterol acetate (Megace) E. procholrperazine (Compazine)
D
20.
Which one of the following statements about treating terminal delirium is true:
A. Family members should leave the room to help decrease the agitation
B. Paradoxical worsening may occur after administration of a minor tranquilizer (e.g. Ativan or Valium)
C. Placing the patient in a dark room will help decrease sensory input and reduce the agitation
D. The drug treatment of choice is an anti-cholinergic medication
E. The drug treatment of choice is an opioid analgesic
B
21.
Which one of the following statements about depression at end-of-life is true:
A. Clinical depression is a normal stage of the dying process
B. Depression associated with HIV is more difficult to treat than in cancer patients
C. Feelings of hopelessness/worthlessness are indicators of a clinical depression
D. The degree of appetite and sleep disturbance is predictive of response to anti-depressant medication
E. Tricyclic antidepressants are the first choice for drug therapy
C
22.
The best drug choice to treat dyspnea in the dying patient is:
A. anti-cholinergic/anti-muscarinic (e.g. scopolamine)
B. anti-depressant (e.g. amitriptyline (Elavil))
C. anti-histamine (e.g. diphenhydramine (Benadryl))
D. local airway anesthetic (e.g. inhaled lidocaine)
E. opioid analgesic (e.g. morphine)
E
23.
A 60 y/o woman has metastatic breast cancer with bone and pleural metastases. Her husband brings her
to clinic stating that over the past week she has noted fatigue, thirst and frequent need to urinate. On
examination she is dehydrated and lethargic but arousable, there are no focal neurological findings. Her
only medication is oral morphine. The most likely diagnosis of this new problem is:
A. Brain metastases
B. Hypercalcemia
C. Hyperglycemia
D. Hypernatremia
E. Sepsis
B
24.
The best class of drugs to treat “death rattle” is a(n):
A. anti-cholinergic/anti-muscarinic (e.g. scopolamine)
B. benzodiazepine (e.g. lorazepam (Ativan))
C. butyrophenone (e.g. haloperidol (Haldol))
D. local airway anesthetic (e.g. inhaled lidocaine)
E. opioid analgesic (e.g. morphine)
A